This Review focuses on research in mouse models pursued to achieve this goal. Figure 1: Allogeneic peripheral-blood stem-cell transplantation. Clinical GVHD has an acute form and a chronic form.

The team explored the potential of regenerative mesenchymal stem cells in reducing ocular inflammation in GVHD-infected mice.

The contribution of Th17 cells in acute graft-versus-host disease (aGVHD) has been demonstrated in aGVHD mouse models ... examination of biopsies. The non-GVHD controls were asymptomatic allo ...

The regulator has cleared Ryoncil (remestemcel-L) to treat steroid-refractory acute GVHD in paediatric patients aged two months and older. It is derived from MSCs harvested from the bone marrow of ...

Kiji Therapeutics engineered MSCs + IL-10 and CXCR4 offer tighter targeting and greater potency for challenging inflammatory diseases.

The FDA has approved Incyte's axatilimab as a treatment for chronic graft-versus-host disease (GvHD), making it a companion to the company's Jakafi for the disorder. The US regulator has cleared ...

Graft Versus Host Disease (GVHD) is a severe medical condition that can occur after a stem cell or bone marrow transplant. In GVHD, the donor's immune cells attack the recipient's healthy tissues ...

MHC-deficient NCG mice that support human tumor xenographs without rapid onset GvHD, both beginning on Monday, April 28, 2025, at 9:00 a.m. Leveraging AI in Oncology The influence of artificial ...

Considering taking supplements to treat graft versus host disease gvhd? Below is a list of common natural remedies used to treat or reduce the symptoms of graft versus host disease gvhd.

Itolizumab showed significant long-term benefits in acute GVHD, improving complete response duration and failure-free survival. Equillium, Inc. seeks Breakthrough Therapy designation and Accelerated ...